INREMDY

Serial Number 98537246
730

Registration Progress

Application Filed
May 7, 2024
Under Examination
Jun 17, 2025
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jun 17, 2026 154 days

Trademark Image

INREMDY

Basic Information

Serial Number
98537246
Filing Date
May 7, 2024
Published for Opposition
April 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Dec 15, 2025
Application
Pending
Classes
005

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Danielle Rivera

USPTO Deadlines

Next Deadline
154 days remaining
NOA E-Mailed - SOU Required
Due Date
June 17, 2026
Extension Available
Until December 17, 2026

Application History

28 events
Date Code Type Description Documents
Dec 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 15, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 15, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 24, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 24, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 24, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 24, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 24, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 17, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 17, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 17, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Mar 5, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 5, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 5, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 31, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 31, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 31, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 11, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 11, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 11, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 11, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 7, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 7, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers

Classification

International Classes
005